Skip to main content



March 2024

By Pharmaceutical Press

Key lessons from Digital Health Rewired 2024

For the TLDR, these were the key topics of conversation at Digital Health Rewired 2024:

  • The national drive for digital transformation in the NHS
  • The complexity of digital transformation and resistance to change
  • The sustainability of the NHS
  • The NHS app and exciting developments

One week on from Digital Health Rewired 2024 and Licensing Sales Manager Piers Berry along with the Editorial team Anna McLachlan, Laura Pham, and India Smith have had a moment to pause and reflect on what was learnt at the busy conference.

Digital Health Rewired 2024

Editorial team’s key findings

The national drive for digital transformation in the NHS was at the heart of Digital Health Rewired 2024.

The question was posed, if the aim is to become the most digitally advanced and productive healthcare system in the world, how can data and technology help to achieve this?

Senior leadership from Trusts across the country shared lessons learnt from digital transformation programmes.

The key theme being that such changes are not merely ‘IT projects’, but rather, they are complex change projects requiring far-reaching cultural shifts.

Resistance to change is a common barrier and strategies to mitigate this include CEO-led projects as well as a focus on interoperable, user-driven systems.

The sustainability of the NHS was also a hot topic, and two significant shifts were at the forefront of discussions.

Firstly, the move away from a reactive system of care, to a more proactive population health model.

Secondly, empowering patients to have agency over their own health.

The NHS app is helping to achieve these goals and NHS England showcased exciting developments in this area, including new features and scale-up plans.

Despite the challenges of technological change in a complex human needs-based system, future health outcomes are dependent on it.

The inspiring developments on show in Birmingham prove that when we get it right, the rewards of transformation are huge.

From visitors to our stand Piers saw keen interest in the integration of Pharmaceutical Press content, especially the much-loved British National Formulary into clinical systems, as well as the licensing of Cautionary and Advisory Labels (CALs) for dispensing systems.

Speak to Piers about licensing Pharmaceutical Press content and be sure to keep up to date with our social channels for the opportunity to meet us at future events.




MedicinesComplete is aimed at health professionals and assumes a level of professional training to interpret the information on this site. Information on the selection and clinical use of medicines is designed for prescribers, pharmacists and other health professionals and is not suitable for patients or the general public. All information should be interpreted in light of professional knowledge and supplemented as necessary with specialist publications, and all users are responsible for ensuring appropriate use or reliance on such information. Although RPS make reasonable efforts to update the information on MedicinesComplete, RPS make no representations, warranties or guarantees, whether express or implied, that the content is accurate, complete, or up to date. So far as permitted by law, RPS will not accept liability for damages, in any form, arising from or in relation to MedicinesComplete, or for a temporary inability to access this site. For more information please see our Website Terms and Conditions. © The Royal Pharmaceutical Society, 2024. Copying of MedicinesComplete content without permission is not permitted.

Access the essential knowledge you need today

Medicines Complete.

Instant online access to our essential knowledge 24/7

Book a demo

Pharmaceutical Journal.

The Royal Pharmaceutical Society’s official journal


Pharmacy Knowledge.

Trusted knowledge and revision for tomorrow's pharmacists


Research Journals.

High impact research in pharmaceutical sciences